MGD007
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MGD007, covering 2021-11-10 to 2021-11-10. Get the full timeline:
Most recent: Clinical Trial Update: MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer [Phase 1, Phase 2]